Role of the new growth hormone-releasing secretagogues in the diagnosis of some hypothalamopituitary pathologies.

[1]  F. Casanueva,et al.  Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. , 1995, The Journal of clinical endocrinology and metabolism.

[2]  P. Hindmarsh,et al.  Short stature and growth hormone deficiency , 1995, Clinical endocrinology.

[3]  F. Casanueva,et al.  Plasma growth hormone response to growth hormone‐releasing hexapeptide (GH‐RP‐6) in children with short stature , 1995, Acta paediatrica.

[4]  C. Diéguez,et al.  Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency. , 1995, European journal of endocrinology.

[5]  F. Casanueva,et al.  Influence of metabolic substrates and obesity on growth hormone secretion , 1995, Trends in Endocrinology & Metabolism.

[6]  F. Casanueva,et al.  Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. , 1995, The Journal of clinical endocrinology and metabolism.

[7]  C. Diéguez,et al.  Growth hormone secretion after the administration of GHRP‐6 or GHRH combined with GHRP‐6 does not decline in late adulthood , 1995, Clinical endocrinology.

[8]  F. Casanueva,et al.  Inhibition of growth hormone release after the combined administration of CHRH and GHRP‐6 in patients with Cushing's syndrome , 1994, Clinical endocrinology.

[9]  F. Casanueva,et al.  Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. , 1993, The Journal of clinical endocrinology and metabolism.

[10]  C. Bowers.  A new dimension on the induced release of growth hormone in obese subjects. , 1993, The Journal of clinical endocrinology and metabolism.

[11]  F. Casanueva,et al.  Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP‐6 , 1993, Clinical endocrinology.

[12]  F. Casanueva,et al.  Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. , 1993, The Journal of clinical endocrinology and metabolism.

[13]  P. Sönksen,et al.  The growth hormone deficiency syndrome in adults , 1992, Clinical endocrinology.

[14]  F. Casanueva.  Physiology of growth hormone secretion and action. , 1992, Endocrinology and metabolism clinics of North America.

[15]  T. Badger,et al.  On the actions of the growth hormone-releasing hexapeptide, GHRP. , 1991, Endocrinology.

[16]  A. Root.  Magnetic resonance imaging in hypopituitarism. , 1991, Journal of Clinical Endocrinology and Metabolism.

[17]  G. Forloni,et al.  Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function. , 1990, Endocrinology.

[18]  M. Thorner,et al.  Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. , 1990, The Journal of clinical endocrinology and metabolism.

[19]  N. Skakkebaek,et al.  BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS , 1989, The Lancet.

[20]  J. Konishi,et al.  Hypothalamic-pituitary function in growth hormone-deficient patients with pituitary stalk transection. , 1988, The Journal of clinical endocrinology and metabolism.

[21]  C. Diéguez,et al.  GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES , 1988, Clinical endocrinology.

[22]  O. Sartor,et al.  Parallel studies of His-DTrp-Ala-Trp-DPhe-Lys-NH2 and human pancreatic growth hormone-releasing factor-44-NH2 in rat primary pituitary cell monolayer culture. , 1985, Endocrinology.

[23]  F. Momany,et al.  Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. , 1980, Endocrinology.

[24]  J. V. Van Wyk,et al.  High incidence of perinatal insult in children with idiopathic hypopituitarism. , 1980, The Journal of pediatrics.

[25]  J. Tanner,et al.  Aetiology of idiopathic growth hormone deficiency in England and Wales. , 1977, Archives of disease in childhood.